Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cerilliant
McKesson
Chinese Patent Office
Medtronic
Covington
Chubb
Cipla
Boehringer Ingelheim

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090289

« Back to Dashboard

NDA 090289 describes LETROZOLE, which is a drug marketed by Accord Hlthcare, Actavis Totowa, Apotex Inc, Dr Reddys Labs Ltd, Fresenius Kabi Oncol, Hikma Pharms, Impax Labs, Indicus Pharma, Jiangsu Hengrui Med, Lannett Co Inc, Mylan, Natco Pharma Ltd, Sun Pharm Inds Ltd, Synthon Pharms, Teva Pharms, Vintage Pharms Llc, and West-ward Pharms Int, and is included in eighteen NDAs. It is available from seventeen suppliers. Additional details are available on the LETROZOLE profile page.

The generic ingredient in LETROZOLE is letrozole. There are twenty-four drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the letrozole profile page.
Summary for 090289
Tradename:LETROZOLE
Applicant:Teva Pharms
Ingredient:letrozole
Patents:0
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Pharmacology for NDA: 090289
Mechanism of ActionAromatase Inhibitors
Suppliers and Packaging for NDA: 090289
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LETROZOLE letrozole TABLET;ORAL 090289 ANDA Teva Pharmaceuticals USA Inc 0093-7620 N 0093-7620-56
LETROZOLE letrozole TABLET;ORAL 090289 ANDA Rebel Distributors Corp 42254-243 E 42254-243-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Jun 3, 2011TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
Merck
Cerilliant
Cipla
Deloitte
Chubb
Dow
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.